CSS LLC’s Filana Therapeutics FLNA Stock Holding History

CSS LLC’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,381	Closed	-$355K	–	1303
2021 Q4	$366K	Sell	8,381 -17,419	-68%	-$913K	0.01%	752
2021 Q3	$1.6M	Buy	25,800 +16,634	+181%	+$1.39M	0.07%	296
2021 Q2	$783K	Buy	+9,166	New	+$491K	0.03%	470

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

CSS LLC's FLNA Position: Q1 2022 in Review

CSS LLC sold out of Filana Therapeutics (FLNA) in Q1 2022, closing a stake of 8,381 shares — an estimated $355K sold.

CSS LLC first reported a position in FLNA in Q2 2021 and held it in 3 quarters. The position peaked at $1.6M in Q3 2021. 163 funds tracked by Wall St. Rank hold FLNA as of Q1 2022.

CSS LLC reported no remaining Filana Therapeutics position as of Q1 2022 after selling out during the quarter.
CSS LLC sold 8,381 Filana Therapeutics shares in Q1 2022, an estimated $355K.
CSS LLC first reported a position in Filana Therapeutics in Q2 2021 and held it in 3 quarters.
CSS LLC's Filana Therapeutics position peaked at $1.6M in Q3 2021.
163 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.